title: Melatonin: a suitable agent for depression associated with stroke?
authors.forename: Ertugrul
authors.initials: E
authors.lastname: Cam
authors.forename: Burak
authors.initials: B
authors.lastname: Yulug
authors.forename: Nurettin
authors.initials: N
authors.lastname: Cengiz
authors.forename: Ester
authors.initials: E
authors.lastname: Poelkin
authors.forename: Dogan
authors.initials: D
authors.lastname: Isýk
authors.forename: Mustafa
authors.initials: M
authors.lastname: Bakar
authors.forename: Erol
authors.initials: E
authors.lastname: Ozan
authors.forename: Ertugrul
authors.initials: E
authors.lastname: Kilic
mesh_terms: D000818:Animals; D000975:Antioxidants / Q000627:therapeutic use*; D002544:Cerebral Infarction / Q000150:complications / Q000188:drug therapy / Q000523:psychology; D003866:Depressive Disorder / Q000209:etiology* / Q000523:psychology; D006801:Humans; D002546:Ischemic Attack, Transient / Q000150:complications / Q000523:psychology; D008550:Melatonin / Q000627:therapeutic use*; D051379:Mice; D020521:Stroke / Q000150:complications* / Q000523:psychology
chemical_list: D000975:Antioxidants; D008550:Melatonin